
15 Sep 2026
AlphaPai raises $50M Series B for AI investment research tools
AlphaPai, an AI investment-research assistant built by Rabyte Technology (讯兔科技) for professional investors, said it closed a US$50 million Series B — its third financing round in the past year. Strategic backers named in the company release include China Insurance Investment and GF Xinde Investment Management, with Qiming Venture Partners, Ambrum Capital, Next Capital, Trustar Capital, and Eastern Bell Capital also participating; China Renaissance was exclusive financial advisor.
Same-day primary capital is going into software professional investors use before they buy or sell. Insurance and securities-linked backers on this Series B point to demand for AI inside research desks — not another lab-pacing echo.
AlphaPai, an AI investment-research assistant developed by financial AI company Rabyte Technology (讯兔科技) for professional investors, announced via PR Newswire Asia on 15 Sep 2026 that it completed a Series B of US$50 million. Series B is mid-stage funding — a growth round after seed money and Series A, not a first check. The company said this is its third consecutive financing round in the past year. That company release, dated Hong Kong, Sept. 15, 2026, 13:10 +08, is the filing event. These are company claims.
What the product is, as the company describes it: software that helps professional investors do investment research — the analyst and portfolio-manager work that happens before a buy or sell, such as reading filings, comparing companies, and writing notes. An AI workstation is software for those workflows, not a human financial adviser.
Named participants, as the release lists them: China Insurance Investment, described as the national investment platform for China’s insurance industry; GF Xinde Investment Management, the private-equity arm of GF Securities; plus Qiming Venture Partners, Ambrum Capital, Next Capital, Trustar Capital, and Eastern Bell Capital, alongside existing shareholders. China Renaissance continued as exclusive financial advisor. None was printed beyond the US$50 million total. The English company PR states US$50 million — this desk is not converting a Chinese RMB headline as fact.
Use of proceeds, as the company tells it: increase research and development in models and products; expand its multi-asset client base — more than one asset class, such as stocks and bonds; deepen industry collaboration; cultivate its home market; and advance an overseas footprint.
Scale, as the same release has it: more than 120,000 professional users across over 8,000 financial institutions and asset managers.
Product timeline, still the company’s: PaiWork, an AI investment-research workstation, launched in April 2026. The company says it brings financial data, research tools, productivity software, and knowledge bases into one working environment. In June 2026 it introduced iRaB — Investment Research Agent Benchmark, a test of how AI handles real research tasks — and the ORE, or Open Research Ecosystem, partner program, with more than 40 brokerage research institutes and data providers.
Luodan Li, founder and chief executive, is named on the release. His quotes are color only and stay in Sources.
RELATED
- Flam raises $40M Series B to scale AI interactive content
- Nuance Labs raises $50M Series A to build real-time face-to-face AI
- Cornelis raises $205M and launches Active Compute Fabric for AI networking
- Anthropic launches Claude for Financial Advisors, wiring Claude into wealth-tech stacks
- Hanwha lists PLUS Korea HBM and AI semiconductor materials ETFs
- Tandem Health raises $100M Series B to build an AI clinic OS for Europe
- Exein raises $270M at $1.7B to secure Physical AI machines
- Temporal raises $550M Series E at a $12.55B valuation
- EUCLYD raises more than €200M Series A for efficient AI inference chips




















